Literature DB >> 30786196

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

James A McKinnell1, Jamie P Dwyer2, George H Talbot3, Lynn E Connolly4, Ian Friedland4, Alex Smith4, Adrian M Jubb4, Alisa W Serio4, Kevin M Krause4, George L Daikos5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30786196     DOI： 10.1056/NEJMc1807634

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

Review 1.  Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Molly Hayes; Jeffrey S Gerber; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

Review 2.  Is it time to move away from polymyxins?: evidence and alternatives.

Authors:  Rajeev Soman; Yamuna Devi Bakthavatchalam; Abinaya Nadarajan; Hariharan Triplicane Dwarakanathan; Ramasubramanian Venkatasubramanian; Balaji Veeraraghavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-02       Impact factor: 3.267

3.  Estimating the size of the United States market for new antibiotics with activity against carbapenem-resistant Enterobacteriaceae.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

4.  Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level.

Authors:  Yohei Doi; David van Duin
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

5.  Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018.

Authors:  Joseph D Lutgring; Rocío Balbuena; Natashia Reese; Sarah E Gilbert; Uzma Ansari; Amelia Bhatnagar; Sandra Boyd; Davina Campbell; Jake Cochran; Jenn Haynie; Justina Ilutsik; Cynthia Longo; Stephanie Swint; J Kamile Rasheed; Allison C Brown; Maria Karlsson
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

6.  Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients".

Authors:  Marco Falcone; Giusy Tiseo
Journal:  Antimicrob Agents Chemother       Date:  2022-07-18       Impact factor: 5.938

Review 7.  Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.

Authors:  Aaron Matlock; Joshua Allan Garcia; Kayvan Moussavi; Brit Long; Stephen Yuan-Tung Liang
Journal:  Intern Emerg Med       Date:  2021-05-06       Impact factor: 5.472

8.  Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data.

Authors:  Cornelius J Clancy; Brian A Potoski; Deanna Buehrle; M Hong Nguyen
Journal:  Open Forum Infect Dis       Date:  2019-07-28       Impact factor: 3.835

9.  Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics.

Authors:  Michelle M Bellerose; Andrew E Clark; Jung-Ho Youn; Rebecca A Weingarten; Chelsea M Crooks; John P Dekker; Karen M Frank
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

Review 10.  Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN).

Authors:  Stephen Hughes; Mark Gilchrist; Katie Heard; Ryan Hamilton; Jacqueline Sneddon
Journal:  JAC Antimicrob Resist       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.